查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750667

全球神經血管內線圈市場：市場規模、佔有率、趨勢分析（按類型、應用、最終用途和地區）、細分市場預測（2025 年至 2030 年）

Neuroendovascular Coil Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

神經血管內線圈市場規模與趨勢：

預計 2024 年全球神經血管內線圈市場規模將達到 10.4 億美元，2025 年至 2030 年的複合年成長率為 6.5%。

這種成長是由於與人口老化和高血壓、吸煙和糖尿病等生活方式相關的風險因素導致腦動脈瘤和中風發病率不斷上升。

技術進步顯著提高了此手術的有效性和安全性，包括新一代可拆卸、水凝膠塗層和3D複合彈簧圈的開發。根據美國國立衛生研究院（NIH）2025年的數據，美國每年約有79.5萬人中風，其中約61萬人為首次中風。近四分之一的中風倖存者會再次中風。在所有中風病例中，約87%被歸類為缺血性中風，其餘13%為出血性中風。

由於老年族群中動脈瘤等神經系統疾病的發生率較高，老化社會是神經血管內線圈市場的主要驅動力。隨著老年人口的成長，對神經血管內線圈栓塞術等微創治療的需求也隨之成長，因為這些治療比傳統手術更安全，恢復速度也更快。此外，老年患者發生動脈瘤破裂和中風等併發症的風險更高，這進一步增加了對神經血管內線圈的需求。全球醫療保健系統正在適應老齡化社會的需求，增加治療資源並提供優惠的報銷政策，這有助於市場擴張。此外，對改善老年人生活品質的關注也推動了對神經血管內線圈等先進微創治療方案的需求，從而促進了市場的成長。

下圖顯示了2050年經合組織國家65歲及以上人口的預測比例，凸顯了全球老化趨勢。預計韓國（39.8%）、日本（37.7%）和義大利（33.7%）等國家的老齡人口比例將最高，這表明由於預期壽命延長和出生率下降，人口結構正在快速變化。此外，隨著人口老化，中風等疾病的發病率預計將上升，這意味著對與老齡化相關的醫療干預措施和技術（例如神經血管內彈簧圈）的需求將增加。

高血壓是各種血管疾病最重要的危險因子之一，包括腦動脈瘤、中風和其他腦血管異常。其在世界各地的日益普及是推動神經血管內彈簧圈市場擴張的關鍵因素。神經血管內彈簧圈廣泛用於治療因未控制的高血壓引起或加重的腦動脈瘤和血管畸形。高血壓是出血性中風的主要原因。高血壓會導致動脈變窄和硬化，使其更容易阻塞和破裂。包括使用彈簧圈在內的神經血管內治療方法是治療方法。根據英國心臟基金會 (BHF) (2025) 的數據，估計英國約有 30% 的成年人（約 1,600 萬人）患有高血壓，其中高達一半的人未接受有效治療。雖然約有 1,100 萬人已由全科醫生確診，但研究結果表明，可能仍有多達 500 萬成年人未被診斷。總合，英國可能有多達 800 萬人患有未確診或未控制的高血壓。

腦動脈瘤是由於血管變弱並形成膨脹而發生的，是老化社會面臨的重大問題。動脈瘤的風險隨著年齡增加而增加，尤其是在50歲以後。隨著全球老年人口的增加，動脈瘤的發生率也隨之上升，對治療方案的需求也隨之增加。神經血管內彈簧圈是治療這些動脈瘤的首選方法之一，其侵入性比傳統手術更小，因此非常適合有其他健康問題或不適合進行侵入性手術的老年患者。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 神經血管內線圈市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
    • 市場機會分析
    • 市場問題分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL分析

第4章神經血管內線圈市場：按類型分類的業務分析

  • 按類型分類的市場佔有率（2024 年和 2030 年）
  • 按類型分類的儀表板
  • 按類型分類的市場規模預測和趨勢分析（2018-2030）
  • 白金裸線圈
  • 水凝膠塗層彈簧圈

第5章神經血管內線圈市場：按應用分類的業務分析

  • 按應用分類的市場佔有率（2024 年和 2030 年）
  • 特定於應用程式的儀表板
  • 按應用分類的市場規模預測和趨勢分析（2018-2030）
  • 中風
  • 腦動脈瘤
  • 動靜脈畸形（AVM）
  • 其他

6. 神經血管內線圈市場：依最終用途分類的業務分析

  • 按最終用途分類的市場佔有率（2024 年和 2030 年）
  • 最終用途儀表板
  • 按最終用途分類的市場規模預測和趨勢分析（2018-2030 年）
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

7. 神經血管內線圈市場：區域估計和趨勢分析（按技術和最終用途）

  • 各地區市場佔有率（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 按國家/地區（2018-2030 年）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區（2018-2030 年）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 按國家/地區（2018-2030 年）
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區（2018-2030 年）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區（2018-2030 年）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 參與企業概況
  • 企業市場占有率分析（2024年）
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Penumbra, Inc
    • TERUMO CORPORATION
    • Kaneka Medical Europe NV
    • Stryker
    • Lepu Medical Technology（Beijing）Co.,Ltd
    • Balt
    • NeuroSafe Medical Co., Ltd.
    • Johnson &Johnson
    • Boston Scientific Corporation
    • Medtronic
Product Code: GVR-4-68040-577-1

Neuroendovascular Coil Market Size & Trends:

The global neuroendovascular coil market size was estimated at USD 1.04 billion in 2024 and is projected to grow at a CAGR of 6.5% from 2025 to 2030. This growth is attributed to the increasing incidence of cerebral aneurysms and strokes, fueled by aging populations and lifestyle-related risk factors such as hypertension, smoking, and diabetes.

Technological advancements have significantly enhanced procedural efficacy and safety, including developing next-generation detachable, hydrogel-coated, and 3D complex coils. According to the data by NIH 2025, each year, an estimated 795,000 people in the U.S. experience a stroke, with approximately 610,000 of these being first-time occurrences. Nearly one in four stroke survivors will suffer a subsequent stroke. Among all stroke cases, about 87% are classified as ischemic strokes, while the remaining 13% are hemorrhagic strokes.

The aging population significantly drives the neuroendovascular coil market due to the higher prevalence of neurological conditions, such as aneurysms, which are more common in older adults. As the elderly population grows, the demand for minimally invasive treatments, such as neuroendovascular coil embolization, increases, as these procedures are safer and involve quicker recovery than traditional surgery. Additionally, the higher risk of complications in older patients, such as aneurysms bursting or strokes, further boosts the demand for neuroendovascular coils. Healthcare systems worldwide are adapting to the needs of aging populations, increasing treatment resources, and creating favorable reimbursement policies, which helps expand the market. Moreover, the focus on improving the quality of life for elderly individuals enhances the demand for advanced, minimally invasive options such as neuroendovascular coils, contributing to the market's growth.

The below graph presents projected data on the proportion of the population aged 65 and older across various OECD countries by the year 2050, highlighting the global trend of population aging. Countries such as South Korea (39.8%), Japan (37.7%), and Italy (33.7%) are expected to have the highest percentages of elderly individuals, indicating rapid demographic shifts driven by increased life expectancy and declining birth rates. Additionally, it indicates a growing demand for age-related medical interventions and technologies, such as neuroendovascular coils, as the incidence of conditions such as stroke is expected to rise with the aging demographic.

Hypertension is one of the most significant risk factors for a variety of vascular diseases, including cerebral aneurysms, strokes, and other cerebrovascular abnormalities. Its growing prevalence globally is a critical factor driving the expansion of the neuroendovascular coil market. Neuroendovascular coils are widely used in the treatment of brain aneurysms and vascular malformations, which are caused or exacerbated by uncontrolled hypertension. Hypertension is the leading cause of hemorrhagic strokes. It contributes to the narrowing and hardening of arteries, making them more susceptible to blockage or rupture. Neuroendovascular procedures, including the use of coils, are a frontline treatment for hemorrhagic strokes caused by ruptured aneurysms. The increasing global burden of hypertension, especially in low- and middle-income countries where blood pressure control is insufficient, is expected to lead to a rise in stroke cases, thereby propelling the demand for neuroendovascular interventions. According to the British Heart Foundation BHF, 2025, it is estimated that around 30% of UK adults, approximately 16 million people, are living with high blood pressure, and up to half of them are not receiving effective treatment. While about 11 million individuals have been diagnosed by their general practitioner, this suggests that up to 5 million adults may remain undiagnosed. In total, up to 8 million people in the UK could be living with undiagnosed or uncontrolled high blood pressure.

Aneurysms in the brain, which occur when blood vessels weaken and form a bulge, are a significant concern among the aging population. The risk of aneurysms increases with age, particularly after age 50. As the number of elderly individuals rises globally, the occurrence of aneurysms has become more prevalent, fueling demand for treatment options. Neuroendovascular coils are one of the preferred methods for treating these aneurysms, as they involve less invasive techniques than traditional surgery, making them more suitable for elderly patients who may have other health concerns or are not candidates for more invasive procedures.

Global Neuroendovascular Coil Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global neuroendovascular coil market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Bare Platinum Coils
  • Hydrogel-Coated Coils
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Cerebral Infarction
  • Cerebral Aneurysm
  • Arteriovenous Malformation (AVM)
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Neuroendovascular Coil Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of cerebral aneurysms and stroke
      • 3.2.1.2. Growing preference for minimally invasive procedures
      • 3.2.1.3. Technological advancements in coil design
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of devices and procedures
      • 3.2.2.2. Risk of recurrence or incomplete occlusion
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Expansion in emerging markets
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Regulatory and clinical trial complexities
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neuroendovascular Coil Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Bare Platinum Coils
    • 4.4.1. Bare Platinum Coils Market, 2018 - 2030 (USD Million)
  • 4.5. Hydrogel-Coated Coils
    • 4.5.1. Hydrogel-Coated Coils Market, 2018 - 2030 (USD Million)

Chapter 5. Neuroendovascular Coil Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cerebral Infarction
    • 5.4.1. Cerebral Infarction Market, 2018 - 2030 (USD Million)
  • 5.5. Cerebral Aneurysm
    • 5.5.1. Cerebral Aneurysm Market, 2018 - 2030 (USD Million)
  • 5.6. Arteriovenous Malformation (AVM)
    • 5.6.1. Arteriovenous Malformation (AVM) Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Neuroendovascular Coil Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital
    • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.5. Ambulatory Surgery Centers
    • 6.5.1. Ambulatory Surgery Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Specialty Clinics
    • 6.6.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Neuroendovascular Coil Market: Regional Estimates & Trend Analysis by Technology and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Share Analysis, 2024
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Penumbra, Inc
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. TERUMO CORPORATION
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Kaneka Medical Europe N.V.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Stryker
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Lepu Medical Technology (Beijing) Co.,Ltd
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Balt
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. NeuroSafe Medical Co., Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Johnson & Johnson
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Boston Scientific Corporation
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Medtronic
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global neuroendovascular coil market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 10 North America neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 13 U.S. neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 18 Mexico neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Mexico neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 22 Europe neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 28 Germany neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 30 France neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 31 France neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 34 Italy neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Italy neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 36 Spain neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Spain neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 40 Norway neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 42 Denmark neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 43 Denmark neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 45 Sweden neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 46 Sweden neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Sweden neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 53 Japan neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 55 China neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 56 China neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 57 China neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 58 India neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 59 India neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 60 India neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 62 Australia neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 64 South Korea neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 65 South Korea neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 66 South Korea neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 67 Thailand neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 68 Thailand neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Thailand neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 72 Latin America neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Latin America neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 75 Brazil neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Brazil neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 78 Argentina neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Argentina neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 86 South Africa neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 91 UAE neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 92 UAE neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Kuwait neuroendovascular coil market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neuroendovascular coil market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and application outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Neuroendovascular coil market dynamics
  • Fig. 13 Neuroendovascular coil market: Porter's five forces analysis
  • Fig. 14 Neuroendovascular coil market: PESTLE analysis
  • Fig. 15 Neuroendovascular coil market: Type segment dashboard
  • Fig. 16 Neuroendovascular coil market: Type market share analysis, 2024 & 2030
  • Fig. 17 Bare platinum coils market, 2018 - 2030 (USD Million)
  • Fig. 18 Hydrogel-coated coils market, 2018 - 2030 (USD Million)
  • Fig. 19 Neuroendovascular coil market: Application segment dashboard
  • Fig. 20 Neuroendovascular coil market: Application market share analysis, 2024 & 2030
  • Fig. 21 Cerebral infarction market, 2018 - 2030 (USD Million)
  • Fig. 22 Cerebral aneurysm market, 2018 - 2030 (USD Million)
  • Fig. 23 Arteriovenous Malformation (AVM) market, 2018 - 2030 (USD Million)
  • Fig. 24 Neuroendovascular coil market: End use segment dashboard
  • Fig. 25 Neuroendovascular coil market: End use market share analysis, 2024 & 2030
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 27 Ambulatory surgery centers market, 2018 - 2030 (USD Million)
  • Fig. 28 Specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Neuroendovascular coil market revenue, by region
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 75 MEA neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company share analysis, 2024
  • Fig. 86 Strategic framework